Development of a highly sensitive LC-MS/MS method for simultaneous determination of rupatadine and its two active metabolites in human plasma: Application to a clinical pharmacokinetic study. 2015

Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
Department of Pharmaceutical Analysis, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

An easy LC-ESI-MS/MS method was developed and validated for simultaneous determination of rupatadine (RT) and its two active metabolites, namely desloratadine (DT) and 3-hydroxydesloratadine (3-OH-DT), in human plasma. The chromatographic separation was carried out on a C18 column with gradient elution by using methanol and 10mM ammonium acetate containing 0.1% (v/v) formic acid. The lower limit of quantification (LLOQ) was 0.05, 0.035 and 0.035 ng/mL for RT, DT and 3-OH-DT, respectively. The intra- and inter-day precision of analytes were within the range of 1.0-4.7% and 2.2-12.1%, respectively. The intra- and inter-day accuracy of analytes were within the range of -7.7% to 5.2% and -4.1% to 4.8%, respectively. The method was successfully applied to a pharmacokinetic study of RT and its two metabolite DT and 3-OH-DT in healthy volunteers following single (10, 20, 40 mg) and multiple (10 mg) oral doses of rupatadine fumarate tablets.

UI MeSH Term Description Entries
D008297 Male Males
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D003533 Cyproheptadine A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. Antergan,Dihexazin,Periactin,Peritol,Viternum
D005260 Female Females
D005561 Formates Derivatives of formic acids. Included under this heading are a broad variety of acid forms, salts, esters, and amides that are formed with a single carbon carboxy group. Formic Acids,Acids, Formic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
November 2011, Biomedical chromatography : BMC,
Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
February 2009, Journal of pharmaceutical and biomedical analysis,
Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
June 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
September 2021, Journal of pharmaceutical and biomedical analysis,
Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
March 2018, Journal of pharmaceutical and biomedical analysis,
Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
August 2018, Biomedical chromatography : BMC,
Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
March 2013, Biomedical chromatography : BMC,
Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
December 2017, Biomedical chromatography : BMC,
Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
April 2022, Journal of pharmaceutical and biomedical analysis,
Chenglong Sun, and Qian Li, and Liping Pan, and Bing Liu, and Pan Gu, and Junying Zhang, and Li Ding, and Chungyong Wu
September 2014, Bioanalysis,
Copied contents to your clipboard!